Acadia Healthcare Company Inc
$ 14.69
2.73%
26 Dec - close price
- Market Cap 1,356,571,000 USD
- Current Price $ 14.69
- High / Low $ 14.76 / 14.15
- Stock P/E 12.66
- Book Value 34.51
- EPS 1.16
- Next Earning Report 2026-02-26
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.05 %
- ROE 0.04 %
- 52 Week High 47.08
- 52 Week Low 12.63
About
Acadia Healthcare Company, Inc. is a leading provider of behavioral health services, operating a comprehensive network of facilities across the United States and Puerto Rico. Headquartered in Franklin, Tennessee, the company focuses on the development and management of a wide range of services, including inpatient psychiatric care, residential treatment programs, and outpatient substance abuse treatment. With a commitment to improving mental health outcomes, Acadia leverages its operational expertise to deliver high-quality, patient-centered care, positioning itself as a key player in the rapidly expanding mental health sector. The firm’s strategic initiatives and dedication to innovation in therapeutic models underscore its role in addressing critical mental health challenges facing communities today.
Analyst Target Price
$21.21
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-05 | 2025-07-29 | 2025-04-29 | 2025-02-25 | 2024-10-30 | 2024-07-31 | 2024-05-01 | 2024-02-27 | 2023-11-02 | 2023-07-27 | 2023-04-26 | 2023-02-27 |
| Reported EPS | 0.72 | 0.83 | 0.4 | 0.64 | 0.91 | 0.91 | 0.84 | 0.85 | 0.91 | 0.92 | 0.75 | 0.7 |
| Estimated EPS | 0.67 | 0.7044 | 0.357 | 0.7146 | 0.9 | 0.87 | 0.81 | 0.79 | 0.89 | 0.86 | 0.71 | 0.75 |
| Surprise | 0.05 | 0.1256 | 0.043 | -0.0746 | 0.01 | 0.04 | 0.03 | 0.06 | 0.02 | 0.06 | 0.04 | -0.05 |
| Surprise Percentage | 7.4627% | 17.8308% | 12.0448% | -10.4394% | 1.1111% | 4.5977% | 3.7037% | 7.5949% | 2.2472% | 6.9767% | 5.6338% | -6.6667% |
Next Quarterly Earnings
| Dec 2025 | |
|---|---|
| Reported Date | 2026-02-26 |
| Fiscal Date Ending | 2025-12-31 |
| Estimated EPS | 0.1965 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ACHC
2025-12-26 14:08:46
Options traders are showing increased interest in Acadia Healthcare Company, Inc. (ACHC) stock, particularly due to high implied volatility in the Mar 20, 2026 $22.50 Put option. This suggests that the market anticipates a significant price movement for ACHC shares. However, analysts currently rate Acadia Healthcare as a Zacks Rank #5 (Strong Sell), with recent earnings estimate revisions pointing to a less optimistic fundamental outlook.
2025-12-25 20:08:46
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into Acadia Healthcare Company, Inc. (NASDAQ: ACHC) concerning potential corporate wrongdoing by its officers and directors. The firm is encouraging investors who purchased Acadia Healthcare securities before February 28, 2020, and still hold them, to engage with the investigation by visiting their website or contacting their office. This investigation aims to determine if there are valid claims for a class action on behalf of investors.
2025-12-25 11:00:00
Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Acadia Healthcare Company, Inc. The firm encourages investors who purchased Acadia Healthcare securities prior to February 28, 2020, and still hold them, to join the investigation. Investors can find more information about the investigation on the firm's website or by contacting their client relations team.
2025-12-25 08:09:21
Acadia Healthcare (ACHC) has seen significant share price declines over the past one and three years, and more recently over 90 days, despite continued revenue and profit growth. Trading at a substantial discount to analyst targets, the company's valuation narrative suggests it is 43.5% undervalued with a fair value of $25.32, driven by facility expansion and strategic partnerships, though risks like softer Medicaid volumes and legal costs could impact future performance.
2025-12-23 20:09:57
Acadia Healthcare Company's stock has seen a significant decline, down 64.5% year-to-date, prompting questions about its current market valuation. Despite this pessimism, Simply Wall St's analysis suggests the stock is undervalued, scoring 5 out of 6 on valuation checks. Both a Discounted Cash Flow (DCF) analysis and Price-to-Earnings (PE) ratio comparison indicate substantial undervaluation, with the DCF model suggesting a 95.8% undervaluation and the PE ratio highlighting a significant discount compared to industry averages.
2025-12-23 20:09:21
Bronstein, Gewirtz & Grossman, LLC has initiated an investigation into Acadia Healthcare Company, Inc. (ACHC) regarding potential corporate wrongdoing involving its officers and/or directors. The firm is encouraging shareholders who purchased Acadia Healthcare securities before February 28, 2020, and still hold them, to contact them to learn more and potentially assist with the investigation. The representation of investors in such class actions is on a contingency fee basis.
